Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution ; volume:36 ; number:2 ; day:4 ; month:9 ; year:2019 ; pages:59-71 ; date:9.2019
Advances in therapy ; 36, Heft 2 (4.9.2019), 59-71, 9.2019
- Urheber
-
Benvenga, Salvatore
Carlé, Allan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-019-01079-1
- URN
-
urn:nbn:de:101:1-2020020422203929327080
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benvenga, Salvatore
- Carlé, Allan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Generic substitution
Longitudinal analysis of generic substitution
Substitution Policy and Generic Competition
Determinants of generic drug substitution in Switzerland
Determinants of Generic Substitution in the Czech Republic
Margins and market shares: Pharmacy incentives for generic substitution
Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
The importance of the first generic substitution: Evidence from Sweden
Extra costs of integrity: Pharmacy markups and generic substitution in Finland
Extra Costs of Integrity: Pharmacy Markups and Generic Substitution in Finland
Repositioning Generic Drugs: Empirical Findings and Policy Implications
Serotonin receptor subtypes: pharmacological significance and clinical implications
Generic substitution
Longitudinal analysis of generic substitution
Substitution Policy and Generic Competition
Determinants of generic drug substitution in Switzerland
Determinants of Generic Substitution in the Czech Republic
Margins and market shares: Pharmacy incentives for generic substitution
Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
The importance of the first generic substitution: Evidence from Sweden
Extra costs of integrity: Pharmacy markups and generic substitution in Finland
Extra Costs of Integrity: Pharmacy Markups and Generic Substitution in Finland
Repositioning Generic Drugs: Empirical Findings and Policy Implications
Serotonin receptor subtypes: pharmacological significance and clinical implications
Generic substitution
Longitudinal analysis of generic substitution
Substitution Policy and Generic Competition
Determinants of generic drug substitution in Switzerland
Determinants of Generic Substitution in the Czech Republic
Margins and market shares: Pharmacy incentives for generic substitution
Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
The importance of the first generic substitution: Evidence from Sweden
Extra costs of integrity: Pharmacy markups and generic substitution in Finland
Extra Costs of Integrity: Pharmacy Markups and Generic Substitution in Finland
Repositioning Generic Drugs: Empirical Findings and Policy Implications